A systematic review and meta-analysis of circulating cell-free DNA as a diagnostic biomarker for non-small cell lung cancer

BACKGROUND: Early diagnosis of non-small cell lung cancer (NSCLC) is crucial for treatment. Circulating cell-free DNA (cfDNA) is an extracellular nucleic acid found in serum, and tumor cfDNA circulating in the blood may be used as a biomarker for early diagnosis. The purpose of this study was to eva...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xin, Chi, Yaqian, Peng, Jingcui, Hu, Wenxia, Ding, Cuimin, Li, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264058/
https://www.ncbi.nlm.nih.gov/pubmed/35813759
http://dx.doi.org/10.21037/jtd-22-646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264058/
https://www.ncbi.nlm.nih.gov/pubmed/35813759
http://dx.doi.org/10.21037/jtd-22-646

Ejemplares similares